Illumina (WBO:ILMN) Days Inventory

: 123.78 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

Days Inventory is also known as Days Sales of Inventory (DSI). Illumina's Average Total Inventories for the three months ended in Dec. 2023 was €557 Mil. Illumina's Cost of Goods Sold for the three months ended in Dec. 2023 was €411 Mil. Hence, Illumina's Days Inventory for the three months ended in Dec. 2023 was 123.78.

The historical rank and industry rank for Illumina's Days Inventory or its related term are showing as below:

WBO:ILMN' s Days Inventory Range Over the Past 10 Years
Min: 106.81 Med: 125.19 Max: 142.3
Current: 123.38

During the past 13 years, Illumina's highest Days Inventory was 142.30. The lowest was 106.81. And the median was 125.19.

WBO:ILMN's Days Inventory is ranked worse than
69.43% of 193 companies
in the Medical Diagnostics & Research industry
Industry Median: 65.4 vs WBO:ILMN: 123.38

Illumina's Days Inventory declined from Dec. 2022 (129.45) to Dec. 2023 (123.78).

Inventory Turnover measures how fast the company turns over its inventory within a year. Illumina's Inventory Turnover for the three months ended in Dec. 2023 was 0.74.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Illumina's Inventory-to-Revenue for the three months ended in Dec. 2023 was 0.54.

Illumina Days Inventory Historical Data

The historical data trend for Illumina's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Illumina Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

124.83

134.77

103.29

110.05

121.50

Illumina Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Inventory																129.45	122.52	124.34	128.25	123.78

Competitive Comparison

For the Diagnostics & Research subindustry, Illumina's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Illumina Days Inventory Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's Days Inventory distribution charts can be found below:

* The bar in red indicates where Illumina's Days Inventory falls into.

Illumina Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Illumina's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (536.192	+	538.279)	/	2 )	/	1613.92	*	365
=	537.2355					/	1613.92	*	365
=	121.50

Illumina's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (576.255	+	538.279)	/	2 )	/	410.816	*	365 / 4
=	557.267					/	410.816	*	365 / 4
=	123.78

Illumina (WBO:ILMN) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Illumina's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	410.816	/	557.267
	=	0.74

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Illumina's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	557.267	/	1028.874
	=	0.54

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Illumina Days Inventory Related Terms

Thank you for viewing the detailed overview of Illumina's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Illumina (WBO:ILMN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (WBO:ILMN) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

ILMN:USA ILMN:Mexico 1ILMN:Italy ILU:Germany

Address

5200 Illumina Way, San Diego, CA, USA, 92122

Website

https://www.illumina.com

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates about 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (about 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.